Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
hAEC for Bronchial Fistula
NCT02959333Phase 1Unknown
- Sponsor
- The Second Affiliated Hospital of Fujian Medical University
- Start
- Oct 2016
- Primary completion
- Oct 2017
- Modality
- Mesenchymal Stem Cells
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of human amniotic epithelial stem cells in bronchopleural fistula (BPF), sponsored by The Second Affiliated Hospital of Fujian Medical University. Primary endpoint: median time for fistula closure at 12 weeks. Status: unknown.
02
Drugs
human amniotic epithelial stem cells
03
Conditions
bronchopleural fistula (BPF)
Beyond the preview
Go deeper on NCT02959333.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02959333.